1. Home
  2. NAMS vs AAP Comparison

NAMS vs AAP Comparison

Compare NAMS & AAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • AAP
  • Stock Information
  • Founded
  • NAMS 2019
  • AAP 1929
  • Country
  • NAMS Netherlands
  • AAP United States
  • Employees
  • NAMS N/A
  • AAP N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • AAP Auto & Home Supply Stores
  • Sector
  • NAMS Health Care
  • AAP Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • AAP Nasdaq
  • Market Cap
  • NAMS 3.1B
  • AAP 3.7B
  • IPO Year
  • NAMS N/A
  • AAP N/A
  • Fundamental
  • Price
  • NAMS $32.86
  • AAP N/A
  • Analyst Decision
  • NAMS Strong Buy
  • AAP Hold
  • Analyst Count
  • NAMS 9
  • AAP 19
  • Target Price
  • NAMS $41.89
  • AAP $52.34
  • AVG Volume (30 Days)
  • NAMS 974.1K
  • AAP 1.7M
  • Earning Date
  • NAMS 11-05-2025
  • AAP 11-13-2025
  • Dividend Yield
  • NAMS N/A
  • AAP 1.90%
  • EPS Growth
  • NAMS N/A
  • AAP N/A
  • EPS
  • NAMS N/A
  • AAP N/A
  • Revenue
  • NAMS $64,006,000.00
  • AAP $8,737,327,000.00
  • Revenue This Year
  • NAMS N/A
  • AAP N/A
  • Revenue Next Year
  • NAMS $1.67
  • AAP $0.97
  • P/E Ratio
  • NAMS N/A
  • AAP N/A
  • Revenue Growth
  • NAMS 762.15
  • AAP N/A
  • 52 Week Low
  • NAMS $14.06
  • AAP $28.89
  • 52 Week High
  • NAMS $34.62
  • AAP $70.00
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 72.18
  • AAP 38.63
  • Support Level
  • NAMS $27.15
  • AAP $60.57
  • Resistance Level
  • NAMS $34.59
  • AAP $62.85
  • Average True Range (ATR)
  • NAMS 1.47
  • AAP 2.06
  • MACD
  • NAMS 0.50
  • AAP -0.65
  • Stochastic Oscillator
  • NAMS 73.37
  • AAP 0.00

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About AAP Advance Auto Parts Inc.

Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.

Share on Social Networks: